Clinton grants S.Africa more control over AIDS programme

August 8, 2012 by Nicolas Revise

US Secretary of State Hillary Clinton on Wednesday gave South Africa greater control over its AIDS programme, which Washington has spent $3.2 billion ramping up over the last eight years.

US aid began in 2004, when South Africa was an international pariah for then president Thabo Mbeki's refusal to accept that AIDS was caused by a virus. His health minister advocated beetroot and garlic instead of medication for treatment.

Now the country runs the world's largest AIDS treatment programme, with more than 1.2 million people currently receiving medication. About 5.7 million, or more than one in 11 South Africans, have HIV -- more people than in any other country.

"South Africa and the entire region has a brighter and healthier and more secure future," Clinton said while visiting a clinic in the Cape Town township of Delft.

"Even as we take a moment to say 'well done', we cannot make the mistake of thinking that our job is done," she said. "The disease is still very dangerous."

Currently the United States funds an array of programmes and clinics directly. Under the new arrangement, South Africa will gradually take over management of those programmes and patients will be shifted into the public health system.

"Some people may hear 'South Africa is in the lead' and think that it means that the US is bowing out," Clinton said. "Let me say this clearly: the US is not going anywhere."

"The partnership is changing for the better," she said. "Our goal is no new patients -- zero."

"South Africa will become the first country in Africa to plan, manage and pay for more of your own efforts to combat the epidemic," Clinton said in a speech later in the day. "The United States will continue to provide funding and technical support through our PEPFAR programme."

The change to the South African programme comes as the United States grapples with its own budget issues at home. AIDS activists have already voiced concern about possible cuts to PEPFAR, credited with transforming treatment in poor countries.

As the richest country in Africa, South Africa has far more resources than any of its neighbours to combat the disease.

According to UN data, the United States provides almost half the world's funding for AIDS assistance -- mainly through PEPFAR, the President's Emergency Plan for AIDS Relief.

That has helped bring about dramatic changes in hard-hit countries like South Africa, where Clinton cited a litany of success.

The rate of newborns catching HIV from their mothers during childbirth has fallen from 8 percent in 2008 to 2.7 percent last year.

More than 6.8 million South Africans have undergone HIV testing and counselling, and 556,000 orphans have received care through the scheme.

Clinton has been on an African tour since July 31, having already visited Senegal, Uganda, South Sudan, Kenya and Malawi. On Thursday she heads on to Nigeria, Ghana and Benin.

Clinton has repeatedly advocated "partnerships" with Africa, hoping to lure countries attracted by China's massive investment across the continent, which has drawn accusations that Beijing is seeking mainly to extract resources to feed its own growing economy.

She urged South Africa to follow the legacy of its first black president Nelson Mandela, who led the transition from white-minority rule 18 years ago.

"The man who did so much to shape the history of a free South Africa has never stopped thinking about the future of South Africa," she said.

"That is the true legacy of president Mandela -- calling all of us to complete the work he started. To overcome the obstacles, the injustices, the mistreatments that everyone, every one of us will encounter at some point in our lives."

Explore further: South Africa unveils plan to halve HIV infections

Related Stories

South Africa unveils plan to halve HIV infections

December 1, 2011
President Jacob Zuma on Thursday unveiled a plan to halve the number of HIV infections over the next five years, cementing South Africa's turnaround from years of deadly denialism.

S.Africa in $208 mln AIDS drug venture with Swiss Lonza

February 10, 2012
South Africa on Friday unveiled plans for a 1.6 billion rand ($208 million, 157 million euro) pharmaceutical plant, in a joint venture with Swiss biochemicals group Lonza to produce anti-AIDS drugs.

UN sees 'massive' fall in South Africa AIDS cases

January 19, 2012
South Africa, home to the highest number of HIV cases in the world, should see a massive reduction by the end of the decade after a sea-change in government policy, a UNAIDS official said Thursday.

Recommended for you

Study suggests a way to stop HIV in its tracks

December 1, 2017
When HIV-1 infects an immune cell, the virus travels to the nucleus so quickly there's not enough time to set off the cell's alarm system.

Discovery puts the brakes on HIV's ability to infect

November 30, 2017
Viewed with a microscope, the virus faintly resembles a pineapple—the universal symbol of welcome. But HIV, the virus that causes AIDS, is anything but that. It has claimed the lives of more than 35 million people so far.

Rising levels of HIV drug resistance

November 30, 2017
HIV drug resistance is approaching and exceeding 10% in people living with HIV who are about to initiate or reinitiate first-line antiretroviral therapy, according to the largest meta-analysis to date on HIV drug resistance, ...

Male circumcision and antiviral drugs appear to sharply reduce HIV infection rate

November 29, 2017
A steep drop in the local incidence of new HIV infections accompanied the rollout of a U.S.-funded anti-HIV program in a large East-African population, according to a study led by researchers at Johns Hopkins Bloomberg School ...

Combination HIV prevention reduces new infections by 42 percent in Ugandan district

November 29, 2017
A study published today in the New England Journal of Medicine provides real-world evidence that implementing a combination of proven HIV prevention measures across communities can substantially reduce new HIV infections ...

Research on HIV viral load urges updates to WHO therapy guidelines

November 24, 2017
A large cohort study in South Africa has revealed that that low-level viraemia (LLV) in HIV-positive patients who are receiving antiretroviral treatment (ART) is an important risk factor for treatment failure.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.